StonvexLoading…
StonvexStonvexStonvexCore line items from BCAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $45.99M | $53.78M | $225.98M | $169.80M | $112.61M |
Operating Income | Not available | $19.09M | $87.96M | $65.57M | $43.75M |
Net Income | Not available | $13.79M | $63.06M | $46.64M | $30.95M |
EPS (Diluted) | $0.41 | $0.42 | $1.93 | $1.42 | $0.95 |
Total Assets | Not available | $4.05B | $4.03B | $4.10B | $3.95B |
Total Liabilities | Not available | $3.47B | $3.46B | $3.54B | $3.41B |
Cash & Equivalents | Not available | $411.14M | $399.91M | $559.22M | $430.14M |
Free Cash Flow OCF − CapEx | Not available | $8.30M | $56.94M | $36.13M | $20.27M |
Shares Outstanding | Not available | 32.15M | 32.42M | 32.44M | 32.46M |